BELLEVUE, Wash.--(BUSINESS WIRE)--TranSenda announced today that it will participate in the BioIT Alliance BioMarker project. Biomarkers are among the fastest growing tools of biomedical research, and many pharmaceutical, biotechnology, and research institutes are struggling to build software solutions to advance biomarker research. By taking an active role in creating viable customer solutions, TranSenda and the BioIT Alliance are attempting to accelerate progress toward personalized medicine.
